Wound healing and antibacterial activities of chondroitin sulfate- and acharan sulfate-reduced silver nanoparticles
Authors:
- Jee Young KimJKJee Young Kim
- Hyun-Seok KimHKHyun-Seok Kim
- Seonho ChoSCSeonho Cho
- Youmie ParkYPYoumie Park
- Yeong Shik KimYKYeong Shik Kim
- 5 September 2013
- journal article
- Published by IOP Publishing in Nanotechnology
- Vol. 24 (39) , 395102
Abstract
For topical applications in wound healing, silver nanoparticles (AgNPs) have attracted much attention as antibacterial agents. Herein, we describe a green-synthetic route for the production of biocompatible and crystalline AgNPs using two glycosaminoglycans, chondroitin sulfate (CS) and acharan sulfate (AS), as reducing agents. The synthetic approach avoids the use of toxic chemicals, and the yield of AgNPs formation is found to be 98.1% and 91.1% for the chondroitin sulfate-reduced silver nanoparticles (CS-AgNPs) and the acharan sulfate-reduced silver nanoparticles (AS-AgNPs), respectively. Nanoparticles with mostly spherical and amorphous shapes were observed, with an average diameter of 6.16 ± 2.26 nm for CS-AgNPs and 5.79 ± 3.10 nm for AS-AgNPs. Images of the CS-AgNPs obtained from atomic force microscopy revealed the self-assembled structure of CS was similar to a densely packed woven mat with AgNPs sprinkled on the CS. These nanoparticles were stable under cell culture conditions without any noticeable aggregation. An approximately 128-fold enhancement of the antibacterial activities of the AgNPs was observed against Enterobacter cloacae and Escherichia coli when compared to CS and AS alone. In addition, an in vivo animal model of wound healing activity was tested using mice that were subjected to deep incision wounds. In comparison to the controls, the ointments containing CS-AgNPs and AS-AgNPs stimulated wound closure under histological examination and accelerated the deposition of granulation tissue and collagen in the wound area. The wound healing activity of the ointments containing CS-AgNPs and AS-AgNPs are comparable to that of a commercial formulation of silver sulfadiazine even though the newly prepared ointments contain a lower silver concentration. Therefore, the newly prepared AgNPs demonstrate potential for use as an attractive biocompatible nanocomposite for topical applications in the treatment of wounds.Keywords
This publication has 47 references indexed in Scilit:
- Noble Metal Nanoparticles Applications in CancerJournal of Drug Delivery, 2012
- Intrinsic therapeutic applications of noble metal nanoparticles: past, present and futureChemical Society Reviews, 2012
- Noble Metal Nanoparticles for Biosensing ApplicationsSensors, 2012
- Controllable Synthesis and Biomedical Applications of Silver NanomaterialsJournal of Nanoscience and Nanotechnology, 2011
- Nanosilver as a new generation of nanoproduct in biomedical applicationsTrends in Biotechnology, 2010
- Inorganic nanomedicine—Part 2Nanomedicine: Nanotechnology, Biology and Medicine, 2010
- Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticlesPhilosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 2010
- Effect of silver on burn wound infection control and healing: Review of the literatureBurns, 2007
- Topical Delivery of Silver Nanoparticles Promotes Wound HealingChemMedChem, 2006
- The bactericidal effect of silver nanoparticlesNanotechnology, 2005